| Patent Number |
Title Of Patent |
Date Issued |
| 4820697 |
4,5-dihydro-4,4-dialkyl-6-(substituted)phenyl-3(2H)-pyridazinones useful as cardiotonic agents |
April 11, 1989 |
| Novel 4,5-dihydro-4,4-dialkyl-6-(substituted)phenyl-3(2H)-pyridazinones having unexpected activity for use as cardiotonic and antihypertensive agents. |
| 4734415 |
Substituted 4,5-dihydro-6-(substituted)-phenyl-3(2H)-pyridazinones and 6-(substituted) phenyl-3( |
March 29, 1988 |
| Substituted 4,5-dihydro-6-(substituted)phenyl-3(2H)-pyridazinone compounds and 6-(substituted)phenyl-3(2H)-pyridazinone compounds and pharmaceutically acceptable salts thereof are useful as cardiotonic and antihypertensive agents.Said compounds cause a significant increase in myocardial |
| 4717730 |
4,5-dihydro-6-(substituted)phenyl-5-methyl-3-(2H)-pyridazinones and pharmaceutical compositions |
January 5, 1988 |
| A novel method of producing 4,5-dihydro-6-(substituted)phenyl-5-methyl-3(2H)-pyridazinone compounds and the corresponding pharmaceutically acceptable salt compounds is provided as well as pharmaceutical compositions containing one or more of the compounds as active components of the |
| 4701453 |
Substituted indeno-pyridazinones |
October 20, 1987 |
| Substituted 2,5-dihydro- and 2,4,4a,5-tetrahydro-3H-indeno[1,2-c]pyridazin-3-ones and pharmaceutically acceptable salts thereof are useful as cardiotonic and antihypertensive agents. |
| 4663313 |
N.sup.6 -tricyclic adenosines for treating hypertension |
May 5, 1987 |
| N.sup.6 -Tricyclic adenosines and pharmaceutically acceptable acid addition salts having highly desirable central nervous system and cardiovascular properties, processes for their manufacture and pharmaceutical composition and methods for using said compounds and compositions are describ |
| 4657898 |
N.sup.6 -substituted adenosines and method of use |
April 14, 1987 |
| N.sup.6 -Substituted diarylalkyladenosines and pharmaceutically acceptable acid addition salts having highly desirable central nervous system and cardiovascular properties, processes for their manufacture and pharmaceutical compositions and methods for using said compounds and compos |
| 4657897 |
N.sup.6 -substituted adenosines for treating pain |
April 14, 1987 |
| N.sup.6 -Substituted diarylalkyladenosines and pharmaceutically acceptable acid addition salts having highly desirable central nervous system and cardiovascular properties, processes for their manufacture and pharmaceutical compositions and methods for using said compounds and compos |
| 4626526 |
(S)-N.sup.6 -2-hydroxypropyladenosines |
December 2, 1986 |
| (S)-N.sup.6 -2-Hydroxypropyladenosines and pharmaceutically acceptable acid addition salts having highly desirable antihypertensive properties, processes for their manufacture and pharmaceutical compositions and methods for using said compounds and compositions are described. |
| 4607037 |
Cardiotonic 2(1H)-pyridinones |
August 19, 1986 |
| Certain 2(1H)-pyridinones are cardiotonic agents. Methods for their preparation and use are disclosed. |
| 4602019 |
Indeno[1,2-c]pyridazin-3-one derivatives useful as cardiotonic and antihypertensive agents |
July 22, 1986 |
| Substituted 2,5-dihydro- and 2,4,4a,5-tetrahydro-3H-indeno[1,2-c]pyridazin-3-ones and pharmaceutically acceptable salts thereof are useful as cardiotonic and antihypertensive agents. |
| 4593019 |
N.sup.6 -tricyclic adenosines |
June 3, 1986 |
| N.sup.6 -Tricyclic adenosines and pharmaceutically acceptable acid addition salts having highly desirable central nervous system and cardiovascular properties, processes for their manufacture and pharmaceutical compositions and methods for using said compounds and compositions are de |
| 4521416 |
4,5-Dihydro-6-[(substituted)-1H-imidazol-4-yl or 5-yl]-3(2H)-pyridazinones and 6-[(substituted)- |
June 4, 1985 |
| 4,5-Dihydro-6-[(substituted)-1H-imidazol-4-yl or 5-yl]-3(2H)-pyridazinones 6-[(substituted)-1H- imidazol-4-yl or 5-yl]-3(2H)-pyridazinones and pharmaceutically acceptable acid addition salts thereof are useful as cardiotonic and antihypertensive agents.The above compounds cause a signifi |
| 4507294 |
Imidazo[1,2-a]pyrazines |
March 26, 1985 |
| There are disclosed herein certain substituted imidazo[1,2-a]pyrazine compounds which are useful in the treatment of peptic ulcer diseases. |
| 4503061 |
Substituted phenyl-pyridinones as cardiotonic agents |
March 5, 1985 |
| Certain 2(1H)-pyridinones are cardiotonic agents. Methods for their preparation and use are disclosed. |
| 4464372 |
Imidazo[1,2-b]pyridazines |
August 7, 1984 |
| There are disclosed herein certain substituted imidazo[1,2-b]pyridazine compounds which are useful in the treatment of peptic ulcer diseases. |
| 4452788 |
Substituted 8-phenylxanthines |
June 5, 1984 |
| Substituted 8-phenylxanthines and their use as bronchodilators is described. Methods for their preparation and use as well as pharmaceutical compositions containing them are also described. |
| 4450164 |
Imidazo[1,2-A]pyridines and use |
May 22, 1984 |
| This invention relates to imidazo[1,2-a]pyridine derivatives which are useful in the treatment of peptic ulcer diseases. |
| 4428962 |
Indoles in treatment of peptic ulcers |
January 31, 1984 |
| There are disclosed herein certain indole derivatives which are useful in the treatment of peptic ulcer diseases. |
| 4409226 |
Imidazo[1,5-a]pyridines |
October 11, 1983 |
| The invention relates to imidazo[1,5-a]pyridine derivatives which are useful in the treatment of peptic ulcer diseases. |
| 4361567 |
Treatment of peptic ulcer disease |
November 30, 1982 |
| Disclosed herein are certain imidazo[1,5-a]pyridines, and pharmaceutical compositions containing them as the active ingredient for treatment and promotion of healing of peptic ulcer disease by virtue of their antisecretory and cytoprotective properties. |
| 4358454 |
1,3,4-Triazolo[1,5-a]pyridines |
November 9, 1982 |
| There are disclosed herein certain 1,3,4-triazolo[1,5-a]pyridine compounds which are useful in the treatment of peptic ulcer diseases. |
| 4358453 |
1,2,4-Triazolo[4,3-a]pyridines |
November 9, 1982 |
| There are disclosed herein certain 1,2,4-triazolo-[4,3-a]pyridine compounds which are useful in the treatment of peptic ulcer diseases. |
| 4353905 |
Substituted 4,5-dihydro-6-[4-(1H-imidazol-1-yl)phenyl]-3(2H)-pyridazinones and 6-[4-(1H-imid |
October 12, 1982 |
| Substituted 4,5-dihydro-6-[4-(1H-imidazol-1-yl)-phenyl]-3(2H)-pyridazinone compounds and 6-[4-(1H-imidazol-1-yl)phenyl]-3(2H)-pyridazinone compounds and pharmaceutically acceptable salts thereof are useful as cardiotonic agents.Said compounds cause a significant increase in myocardial co |
